BioStem Technologies, Inc. Diluted Shares Outstanding (Weighted Average)
BioStem Technologies, Inc. (BSEM) reported Diluted Shares Outstanding (Weighted Average) of 17.33 million shares for the 3-month period ending 2026-06-30, per its S-1 filed 2026-09-18.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-09-18
- BioStem Technologies, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 17.33M shares, a 26.01% decline year-over-year.
- BioStem Technologies, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 23.42M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|
| 2026-06-30 | 17.33M shares S-1 · filed 2026-09-18 | 17.09M shares S-1 · filed 2026-09-18 | |
| 2025-12-31 | 16.73M shares S-1 · filed 2026-09-18 | ||
| 2025-06-30 | 23.42M shares S-1 · filed 2026-09-18 | 23.51M shares S-1 · filed 2026-09-18 | |
| 2024-12-31 | 21.70M shares S-1 · filed 2026-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |